The JI
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
 QUICK SEARCH:   [advanced]


     
 


The Journal of Immunology, 1979, 123: 2588-2592.
Copyright © 1979 by The American Association of Immunologists, Inc.

This Article
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Similar articles in this journal
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Citing Articles
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Staber, F. G.
Right arrow Articles by Tarcsay, L.
Right arrow Search for Related Content
PubMed
Right arrow Articles by Staber, F. G.
Right arrow Articles by Tarcsay, L.

Different Responses of B Lymphocyte Colony-Forming Cells in Bone Marrow and Spleen of Mice Injected with Bacterial Cell-Wall Components1

Fritz Georg Staber2, Judith E. Layton and Lajos Tarcsay

From the Walter and Eliza Hall Institute of Medical Research, Royal Melbourne Hospital, Victoria, 3050, Australia and CIBA-GEIGY Ltd., Research Department, Pharmaceuticals Division, Basel, Switzerland

Abstract

The responses of B lymphocyte colony-forming cells (BL-CFC) and hematopoietic colony-forming cells (HP-CFC) to three structurally unrelated chemically highly purified bacterial cell-wall components (BCWC) were studied in vivo. The total femoral BL-CFC content in C57BL/6 mice was found to be decreased approximately 70-fold 6 days after injection of lipid A and approximately 40-fold after injection of the outer membrane lipoprotein of Escherichia coli. Murein caused a much smaller decrease. In contrast to the marrow, the total splenic BL-CFC content did not change significantly after injection of any of the three BCWC. The response pattern of HP-CFC differed completely from that of BL-CFC. Although in the marrow only slight fluctuations were observed, the total spleen content of HP-CFC increased markedly after injection of either lipid A or lipoprotein but not after murein injection.

The decreased incidence of marrow BL-CFC was found to be maximal 4 to 6 days after injection, and normal levels of marrow BL-CFC were detectable again 2 weeks after injection. Inhibitory factors produced by marrow cells, especially prostaglandin E, appear not to be responsible for the decreased B lymphocyte colony-forming capacity of post-lipid A or post-lipoprotein marrow. The frequency of immunoglobulin-positive cells was also decreased in the marrow of mice injected with BCWC, but to an extent far too low to account completely for the decreased incidence of BL-CFC.

Footnotes

1 This work was supported by a Research Fellowship from the Deutsche Forschungsgemeinschaft, and by the Anti-Cancer Council of Victoria, the National Health and Medical Research Council, Canberra, and by Contract I-CB-74147 from the National Cancer Institute, Washington, D. C.

2 Please send reprint requests to: Dr. F. G. Staber, Institut für Hämatologie der GSF, Landwehrstr. 61, D-8000 München 2, West Germany.







HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
This Website Copyright © 1979 by The American Association of Immunologists, Inc. All rights reserved.
All Contents Copyright © 1979 by The American Association of Immunologists, Inc. All rights reserved.